Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02657499 · ClinicalTrials.gov registry record

Post Affordable Care Act Evaluation

A clinical trial of Chronic Disease, sponsored by Oregon Health and Science University.

Completed
Registry status
1,939,848
Enrollment target
1
Study location

NCT02657499 is a study of Chronic Disease that has completed, run by Oregon Health and Science University. The registered enrollment target is 1,939,848 participants, above the 49,530-participant average among 48 other Chronic Disease trials with a reported enrollment target (3817% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02657499, a study of Chronic Disease, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
1,939,848 participants
Enrollment target
1
Study location

Study Summary

This innovative study will measure the impact of Affordable Care Act-sponsored Medicaid expansions on access to and utilization of community health center (CHC) services. Building on the investigators prior work that developed a robust community-based research infrastructure within the OCHIN community health information network, the investigator will utilize linked electronic health record data from the OCHIN network of \>400 CHC clinics in 8 states that expanded Medicaid coverage and 8 states that did not expand.

Conditions Studied

Interventions

  • OTHER Medicaid Expansion

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 1,939,848 participants
Start Date 2012-01
Est. Completion 2018-10-24

What the Registry Record Tells You About NCT02657499

The ClinicalTrials.gov registry entry for NCT02657499 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,939,848 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 49,530-participant average among 48 other Chronic Disease trials with a reported enrollment target (3817% higher). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Medicaid Expansion is the first listed.

NCT02657499 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT02657499 about?

NCT02657499 is a clinical study titled "Post Affordable Care Act Evaluation". This innovative study will measure the impact of Affordable Care Act-sponsored Medicaid expansions on access to and utilization of community health center (CHC) services. Building on the investigators prior work that developed a robust community-based research infrastructure within the OCHIN communi...

What is the current status of trial NCT02657499?

This trial is currently completed. The enrollment target is 1,939,848 participants. The study started on 2012-01. Estimated completion is 2018-10-24.

What conditions does trial NCT02657499 study?

This clinical trial studies the following conditions: Chronic Disease.

What interventions are being tested in trial NCT02657499?

The interventions under investigation include: Medicaid Expansion (OTHER).

Who is sponsoring clinical trial NCT02657499?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02657499 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.